Ann: ResAppDx to be Formally Evaluated by Doctors Without Borders, page-89

Would tend to agree, however, in our case you can only use the data if you can corroborate it against a proven outcome.
The MSF guys have been assisting in the operational use of Rap, the data collected so far is unlikely to be used to prove a clinical case, hence their own clinical trials
The data collected so far is therefore informal and wouldn't support FDA etc as I'm aware
Moving to clinical trials means they see the use of it, operationally it works, I'm aware from discussion with TK that they changed the software so that the cough comes first then input the temperature etc later so you can send an untrained person around a room/village testing quickly (the temperature/fever only add a few % accuracy) and check people fast to enable prioritisation for the doctor. The trials so far IMO have been checking whether its operational use is effective and if it can be integrated with data collection or management systems.
FDA might be accepted but MSF may want to prove it themselves but to do that they need to ensure they also have a method of verifying the data same as the hospitals do. Eg X-ray and sputum test, in most cases MSF run on the IMCI tests which they state is inaccurate and leads to a 60% over prescription on antibiotics, that's a cost and a risk of creating bugs with resistance

Terrific they are moving ahead with clinical trials and have allocated a specialist to run this in India, according to another post. We won't have problems getting the numbers as India is the worst county for pneumonia deaths in kids unfortunately. FDA terrific, and now they have decided it is operationally effective then that's fine with me.
I'm also aware that MSF had allocated 300m euro last year to upgrade methods and technology so we may have come in on that funding originally. They were also looking for tuberculosis diagnostics too

Good news, nice confirmation and let's go get our FDA approval